Registration desk that gets biostimulant makers onto the FCO schedule
TL;DR Stimfile is a regulatory desk for small and mid-sized biostimulant and microbial-product makers. It builds the dossier, books the toxicology lab and places the three-zone bio-efficacy trials that India now demands before a product can stay on sale. Makers pay per product, and thousands of products are caught in this squeeze.
In February 2021 India brought biostimulants under the Fertiliser Control Order. Every product now needs its own entry in Schedule VI, which names its composition, the crop it's meant for and the dose[1]. Getting that entry takes GLP or NABL lab analysis, nine toxicity tests and bio-efficacy trials at ICAR or a state agricultural university, run at three doses in three agro-climatic zones[1][2].
Products already on the market were allowed to keep selling on a provisional certificate. That cover has been cut back, with the certificate's validity moved to 16 June 2025[3]. The government's own list shows 9,352 product rows holding provisional certificates, from roughly a thousand makers by my count[4].
Many of them are single-brand firms with no regulatory staff at all.
What it does, in regulatory terms: regulatory filing and trial coordination for biostimulant makers. Stimfile doesn't make, sell or recommend any biostimulant, and it can't run the official efficacy trials itself, which must sit with the national research system[2].
A maker sends its portfolio and Stimfile triages it first - which products match a category and spec already in Schedule VI, which need full data, and which aren't worth registering at all. For the ones that go ahead, it drafts the Form G dossier, books toxicology and heavy-metal tests with accredited labs, writes the trial protocol and places it with university departments in three zones. Then it chases every committee query until the gazette entry appears.
I reframed the seed, which pitched personalised microbiome products for each farm. Under the order each product is a fixed formula approved for a named crop and dose[5], so a blend made per farm would be an unapproved product every single time. Biologicals reach farmers only after they clear this gate, and that is where the help is needed.
The manufacturer or importer pays. Usually that's the founder or head of operations at a firm with 5 to 50 products on a provisional certificate. Who handles it today? A stretched in-house executive, or a pesticide consultant learning the fertiliser rules on the job. My working model is a fixed fee per product dossier plus pass-through costs for labs and trials. No public price for this service exists, so treat that fee as untested.
The window has closed. The March 2025 order moved the provisional certificate date to 16 June 2025[3], the June 2025 order tightened the trial rule to the same crop in all three zones[2], and a September 2025 list put every provisional product on public record[4]. The ministry has issued 19 biostimulant notifications since 2021[6], so the rules keep moving and makers need someone tracking them.
The narrowest figure is the 9,352 provisional product rows in the September 2025 list[4]. Not all of them will get filed, because many brands overlap or will be dropped. One March 2026 notification alone added about 45 crop-specific entries[5], which shows how many files a busy year throws up. Adjacent - a 2025 review puts India's biostimulant market growth at 13% a year, the fastest of the countries it compares[7]. That's context, not your market.
Biome Makers, based in the US and Spain, runs soil-microbiome tests and field trials for input companies to support product claims, but it does not file Indian registrations[8]. In India, contract labs and pesticide registration consultants handle CIB&RC work under the Insecticides Act, and some have moved into fertiliser filings. I couldn't confirm any firm that offers the full biostimulant route, from triage through trial placement to gazette, for small makers. What's missing is a specialist, and India has plenty of generalist consultants already.
| Difficulty | Moderate (41/100) |
| Starting capital | ₹45–80 L |
| Time to launch | 3–5 months |
The paperwork is learnable. The hard part is trial capacity, because university departments set their own fees and calendars and a missed sowing window costs a maker a full season. You also need staff who read gazette changes the week they appear.
Stimfile itself needs no special licence, because it files as each client's authorised agent. Confirm that arrangement with the Controller's office [Requires validation].
Building this outside India? The categories above usually have a local equivalent, so check with your own regulator.
Don't trust AI to interpret the order for a filing. A person reads the gazette text itself before anything is submitted.
Want to work out the AI layer for Stimfile? Talk to Yash →
Here's what can go south -
I think this is a solid, unglamorous service business. If you come from agrochemical regulatory affairs or an agricultural university and know how trials get placed then it's a good fit. If you're hoping to build software first then it is not for you. Before raising money, sign five makers and get one product from first filing to a gazette entry.
Plan for roughly ₹45–80 L, mostly for regulatory staff, trial coordination and working capital while files move through the process.
No licence of your own, since you file as the client's authorised agent. Your clients' products need listing under FCO Schedule VI.
Yes, wherever biostimulants need approval before sale. Each country runs its own process, so you'll need local regulatory knowledge.
The free Stimfile validation kit has the line-by-line capital breakdown, the effort scoring, the FCO and lab-accreditation checklist, a 14-day validation sprint with pass/fail targets, a 90-day launch plan, 10 interview questions for manufacturers, and 5 assumptions to test. Download the kit →
Thinking about building Stimfile or something close to it? The make-or-break work is securing reliable trial slots with research institutes in three zones, and that's the kind of thing I help founders with. If you need a hand, you know where to find me. Talk to Yash →
For illustration only. Names are fictional and ideas hypothetical; sourced facts are real but may be out of date. Nothing here is legal, financial or professional advice, and Yash Khatri is not personally liable for any use of it. Read the full disclaimer.